Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Oxymetazoline manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

oxymetazoline

Eye drops 0.03 % - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303
A pharmaceutical manufacturer with over 25 years of experience that develops and produces fixed-dose and single-entity generic and specialty pharmaceutical products. The company offers an extensive range of injectable dosage forms, including parenterals, and also manufactures oral solids. Its facilities operate under recognised international quality certifications such as EU-GMP, ANVISA, PIC/S and TGA approvals, supporting reliable large-scale production of pharmaceutical products for global export while emphasizing efficacy, affordability and consistent quality.

Manufacturer usually replies in 21 days

oxymetazoline

Nasal drops 0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #34549

Established in 2016, this WHO-GMP certified manufacturer specializes in the production and export of pharmaceutical, nutraceutical, and ayurvedic products, including tablets, capsules, syrups, and injections. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates state-of-the-art manufacturing facilities adhering to stringent GMP guidelines. Its products are distributed across multiple countries worldwide, with registrations in regions such as the Dominican Republic, Philippines, Myanmar, Uzbekistan, Turkmenistan, Iraq, and Kuwait. 

 

Manufacturer usually replies in 14 days

oxymetazoline

Nasal drops 0.5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801

This CTD dossier owner and manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.

Manufacturer usually replies in 30 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Oxymetazoline

Oxymetazoline is a topical decongestant. It is sold over-the-counter as a topical decongestant in the form of Oxymetazoline hydrochloride in nasal sprays. Oxymetazoline nasal spray relieves nasal discomfort in colds, allergies, hay fever, provides relief from sinus congestion and pressure. Oxymetazoline as a nasal decongestant narrows the blood vessels in the nasal passages. It has also been approved to treat persistent facial erythema associated with rosacea in adults and its vasoconstricting properties are used to treat nose bleeds and eye redness due to minor irritation. Children under six are not allowed to use and kids age 6-12 are also given these sprays unless recommended by the doctor. Oxymetazoline is sold in many popular brand names around the world such as Otrivin, Afrin, Operil, Dristan, Dimetapp, Oxyspray, Facimin, Nasivin, Nostrilla, Utabon, Sudafed OM, Vicks Sinex, Zicam, SinuFrin, Drixoral, and Mucinex Full Force. Fruhstorfer of E. Merck Darmstadt developed Oxymetazoline in 1961. It was approved in the USA for topical treatment of persistent facial erythema and in 2020, it also received approval from the USFDA for the treatment of acquired drooping eyelid.

Dosage Forms & Strengths

Oxymetazoline is sold as an intranasal solution of 0.05% concentrate. For temporary relief from Nasal Congestion, the patient has to drop 2-3 gtt of the sprays per nostril. This can be repeated every 12 hours, but more than twice, and should not be used for more than 5 days.

The price of Oxymetazoline

In the USA, the consumer has to pay around $10 for nasal spray 0.05% for a supply of 15 milliliters. This medicine is significantly cheaper in developing countries. In India, the 10ml supply of spray costs around $1.

How does it work?

Oxymetazoline has direct-acting sympathomimetic activity and is an imidazole derivative. Oxymetazoline activates alpha-2 adrenergic receptors by selectively bindings them. When used nasally or ocular administration, it works by constricting the arterioles in the nose and eye. This results in decreased nasal and conjunctival congestion, providing relief from the symptoms.

Finding Oxymetazoline Manufacturers and Suppliers:

The process of finding trusted Oxymetazoline manufacturers and Oxymetazoline suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. In addition, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Oxymetazoline. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.